Islatravir Uses, Dosage, Side Effects and more
Islatravir is under investigation in clinical trial NCT04233216 (Doravirine/islatravir (DOR/ISL) in Heavily Treatment-experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)).
| Trade Name | Islatravir |
| Generic | Islatravir |
| Islatravir Other Names | Islatravir |
| Type | |
| Formula | C12H12FN5O3 |
| Weight | Average: 293.258 Monoisotopic: 293.092417429 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
